Insiders · Profile

Brackmann Christoph

Chief Financial Officer at NovoCure. Filing since 29 Jul 2025. CIK 0002048634

Company

Date

Role

Action

Amount

Of holding

4 Mar 2026

Chief Financial Officer

Sold at will

6,412

$85.31K

3.4%

29 Jul 2025

Chief Financial Officer

Bought

20,000

$231.80K

16.5%

2 decisions on file.